Hologic
LetsGetChecked Nabs FDA Marketing Authorization for Chlamydia, Gonorrhea Test
The assay is the first test for chlamydia and gonorrhea with at-home sample collection to receive marketing authorization, according to the agency.
Hologic Non-COVID Fiscal Q4 Dx Revenues Rise 17 Percent
The firm reported that, excluding COVID-19 testing, its molecular diagnostics business grew 15 percent and overall diagnostics business grew 11 percent.
Hologic Fiscal Q3 Revenues Beat Estimates on Rising Non-COVID Sales
The firm posted double-digit growth in non-COVID-19 molecular diagnostics revenues and continues working to bring its Mobidiag products to the US market.
Hologic Nabs FDA 510(k) Clearance for Respiratory Assay
The multiplex real-time RT-PCR test for SARS-CoV-2, influenza A and B, and RSV is designed for use on the firm's high-throughput Panther Fusion instrument.
Hologic Fiscal Q2 Revenues Drop 29 Percent With Fall in COVID-19 Assay Sales
The firm posted 20 percent organic growth excluding COVID-19-related income and is eyeing potential M&A deals that could "bulk up" its existing businesses.